Form 4: Orchestra BioMed Holdings Director Aryeh Jason Acquires Shares and Stock Options

Director Aryeh Jason acquired 5,376 shares of common stock and 17,068 stock options in Orchestra BioMed Holdings on June 20, 2024.

Summary

• On June 20, 2024, Aryeh Jason, a director of Orchestra BioMed Holdings, acquired 5,376 shares of common stock at $0.00 per share.
• These shares were awarded as restricted stock units (RSUs) that will vest on June 20, 2025.
• Additionally, Mr. Aryeh acquired 17,068 stock options with an exercise price of $7.44.
• These options are exercisable from June 20, 2025, and expire on June 20, 2034.
• Following these transactions, Mr. Aryeh directly owns 68,360 shares of common stock and 17,068 stock options.

Sentiment

Score: 6

Explanation: The sentiment is neutral. It's a routine filing related to stock and option grants to a director. The acquisition of shares and options by a director is generally viewed as a positive sign, but it's not a major event.

Positives

• The acquisition of shares and stock options by a director could be seen as a positive signal, indicating confidence in the company's future prospects.

Industry Context

Form 4 filings are standard practice and provide transparency into the transactions of company insiders, allowing investors to track ownership changes and potential alignment of interests.

Stakeholder Impact

• The transactions may have a minor positive impact on shareholder sentiment due to the director's increased stake in the company.

Key Dates